Daigdigan, Ronald L.

HRN: 28-62-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CEFUROXIME 1.5GM (VIAL)
07/09/2026
07/16/2026
IV
1.5G
Q8
R/O POST OP ADHESIONS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines